Edition:
United Kingdom

Shanghai Pharmaceuticals Holding Co Ltd (2607.HK)

2607.HK on Hong Kong Stock

23.00HKD
3:05am BST
Change (% chg)

HK$0.30 (+1.32%)
Prev Close
HK$22.70
Open
HK$23.00
Day's High
HK$23.15
Day's Low
HK$22.65
Volume
577,433
Avg. Vol
7,237,722
52-wk High
HK$24.25
52-wk Low
HK$18.20

Latest Key Developments (Source: Significant Developments)

Shanghai Pharmaceuticals Says Q1 Net Profit Up 2.1 Percent Y/Y
Friday, 27 Apr 2018 

April 27 (Reuters) - Shanghai Pharmaceuticals Holding Co Ltd <601607.SS>::SAYS Q1 NET PROFIT UP 2.1 PERCENT Y/Y.  Full Article

Shanghai Pharmaceuticals Says ‍Co To Buy 100% Stake In New Century Pharmaceutical, Yide Pharmacy
Friday, 23 Mar 2018 

March 23 (Reuters) - Shanghai Pharmaceuticals Holding Co Ltd <601607.SS>::‍CO TO BUY 100% EQUITY INTEREST IN NEW CENTURY PHARMACEUTICAL, YIDE PHARMACY HELD BY SHANGHAI PHARMACEUTICAL (GROUP).EXPECTED THAT TRANSFER PRICE WILL NOT EXCEED RMB320 MILLION.  Full Article

Shanghai Pharmaceuticals' 2017 Net Profit Up, To Issue Bonds, Debt Financing Instruments
Friday, 23 Mar 2018 

March 23 (Reuters) - Shanghai Pharmaceuticals Holding Co Ltd <601607.SS>2607.HK::SAYS 2017 NET PROFIT UP 10.1 PERCENT Y/Y.SAYS IT PLANS TO ISSUE UP TO 5.0 BILLION YUAN BONDS.SAYS IT PLANS TO ISSUE UP TO 5.0 BILLION YUAN DEBT FINANCING INSTRUMENTS.  Full Article

Shanghai Pharmaceuticals Holding unit receives GMP certificate
Monday, 5 Mar 2018 

March 5(Reuters) - Shanghai Pharmaceuticals Holding Co Ltd <601607.SS>:Says co's Shanghai-based wholly owned unit received goods manufacture practice (GMP) certificate from Shanghai Food and Drug Administration, for therapeutic biological products .Says the valid period is until Feb. 5, 2023.  Full Article

Shanghai Pharmaceuticals Holding units receive GMP certificate
Wednesday, 10 Jan 2018 

Jan 10 (Reuters) - Shanghai Pharmaceuticals Holding Co Ltd <601607.SS>:Says Changzhou-based pharmaceuticals unit received goods manufacture practice (GMP) certificate from Jiangsu Food and Drug Administration, for its products including acyclovir, ganciclovir and production line .Says the valid period is until Dec. 25, 2022.Says Shanghai-based pharmaceuticals unit received goods manufacture practice (GMP) certificate from Shanghai Food and Drug Administration, for its products including flurbiprofen axetil .Says the valid period is until Dec. 26, 2022 .  Full Article

Shanghai Pharmaceuticals Holding unit receives GMP certificate
Friday, 5 Jan 2018 

Jan 5 (Reuters) - Shanghai Pharmaceuticals Holding Co Ltd <601607.SS> ::Says its unit received goods manufacture practice (GMP) certificate from Shandong Food and Drug Administration, for its products including mixture, oral liquid, drops and bulk drug .Says the valid period is until Dec. 25, 2022.  Full Article

Shanghai Pharmaceuticals Holding Announces ‍CSRC's Approval On Issuance Of New Shares
Friday, 29 Dec 2017 

Dec 29 (Reuters) - Shanghai Pharmaceuticals Holding Co Ltd <601607.SS>::ANNOUNCES ‍CSRC'S APPROVAL ON ISSUANCE OF NEW 153.2 MILLION H SHARES AT VALUE OF RMB1 PER SHARE​.  Full Article

Shanghai Pharmaceuticals Holding To Transfer Entire Stake In Shanghai Huashi Asset Management
Tuesday, 19 Dec 2017 

Dec 19 (Reuters) - Shanghai Pharmaceuticals Holding Co Ltd <601607.SS>::ANNOUNCES ‍TRANSFER OF 100% EQUITY INTEREST IN SHANGHAI HUASHI ASSET MANAGEMENT CO TO A CONTROLLING SHAREHOLDER​.DEAL FOR RMB218.1 MILLION​.  Full Article

Shanghai Pharmaceuticals Holding unit receives GMP certificate
Monday, 11 Dec 2017 

Dec 11 (Reuters) - Shanghai Pharmaceuticals Holding Co Ltd <601607.SS> ::* Says its wholly owned unit received goods manufacture practice (GMP) certificate from Shanghai Food and Drug Administration .* Certificate issued pill and Chinese medicine extraction workshop of the unit and the valid period is until Nov. 30, 2022.  Full Article

Shanghai Pharmaceuticals Holding unit receives GMP certificate
Tuesday, 5 Dec 2017 

Dec 5(Reuters) - Shanghai Pharmaceuticals Holding Co Ltd <601607.SS> : :Says its Shanghai-based unit received goods manufacture practice (GMP) certificate from Shanghai Food and Drug Administration.Says the valid period is until Nov. 27, 2022.  Full Article